Skip to the page

Data / Form D filings / Chirality Biosciences, Inc.

Chirality Biosciences, Inc.: Form D filing

Chirality Biosciences, Inc., a company in Farmingdale, NY, filed a Form D with the SEC in 2025. The latest, on October 29, 2025, reports $3.1 million sold of a $4.1 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3 BIOSCIENCE PARK DRIVE, ROOM 508, Farmingdale, NY, 11735
Phone
(516) 672-8623
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2094367

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 29, 2025New notice$4,100,000$3,105,000$995,0009Oct 17, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Arielle GabalskiExecutive Officer, Director
Robert KaytonDirector
Joanna Jennings EagleExecutive Officer

Other companies in New York that filed recently

Every Form D from the week of Oct 27, 2025 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Chirality Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.